HOLX Stock Recent News
HOLX LATEST HEADLINES
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024.
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic (HOLX) closed at $75.65 in the latest trading session, marking a +0.52% move from the prior day.
Hologic (HOLX) concluded the recent trading session at $76.35, signifying a +0.58% move from its prior day's close.
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
In the latest trading session, Hologic (HOLX) closed at $75.64, marking a -0.9% move from the previous day.
Hologic's (HOLX) BCI test is the only genomic test that is approved by various national oncology guidelines.
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The U.S. Food and Drug Administration on Tuesday warned patients and healthcare providers about the potential risk of serious complications arising from the use of Hologic's devices that are implanted in soft tissue.
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.